# Riabni

NDC: 55513-326
Generic name: rituximab-arrx
Labeler / Manufacturer: Amgen, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210106

FDA application: BLA761140

## Active ingredients

- RITUXIMAB: 500 mg/50mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-326"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-326
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=da1c4de7-0e5b-4f72-97ec-7a8d368f085f